Breaking News
About Bayer
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Our products and services are designed to benefit people and improve their quality of life. At the same time, we aim to create value through innovation, growth and high earning power.
Our products help address some of today’s biggest challenges, including global population growth, an aging society and the need to make efficient – and, wherever possible, sustainable – use of natural resources.
In line with our mission “Bayer: Science For A Better Life,” we aim to improve people’s quality of life by preventing, alleviating or curing diseases. We also help provide an adequate supply of high-quality food, feed and renewable plant-based raw materials. For these endeavors, we focus on developing and successfully commercializing innovative products and solutions based on scientific knowledge.
Related Story
Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology
May 11 2023
Bayer and Bicycle Therapeutics, a biotechnology company pioneering a new and differentiated class of therapeutics […]
Telix to Supply Bayer with Illuccix® for Global Phase III Prostate Cancer Study
May 8 2023
Telix Pharmaceuticals today announces that it has entered into an agreement with Bayer AG (Bayer) […]
Bayer Expands Global Clinical Program for NUBEQA® (darolutamide) in Prostate Cancer
March 23 2023
Bayer further expands the global clinical development program for NUBEQA (darolutamide) in prostate cancer. The […]
Bayer’s Bluerock Therapeutics Establishes European Site for Cell Therapy Innovation
June 9 2022
Bayer AG announced today that BlueRock Therapeutics LP (BlueRock), a clinical stage biopharmaceutical company and […]
Illumina Introduces New Pan-Cancer Companion Diagnostic to Match Patients with Rare Genetic Mutations to Targeted Therapy
May 24 2022
Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the […]
Bayer Announces Changes in Executive Leadership Team of Crop Science Division
March 4 2022
Bayer today announced changes in the leadership team of its Crop Science division, with Kelly […]
Leaps by Bayer Leads $80M Series A Financing for Cellino Biotech to Autonomize Stem Cell Therapy Manufacturing
January 27 2022
Cellino Biotech, Inc., an autonomous cell therapy manufacturing company, today announced the completion of a […]
Bloom Science Raises USD $12 Million in Series A Financing
December 10 2021
San Diego based biotech company Bloom Science announced today it successfully closed a USD $12 Million Series A […]
Bayer Announces Christoph Koenen as New Global Head of Clinical Development and Operations within Pharmaceuticals Research and Development at Bayer
November 5 2021
Bayer today announced Christoph Koenen as the new Global Head of Clinical Development and Operations […]
Bayer to Invest Over €400 Million to Increase Access to Modern Contraception
October 6 2021
Bayer today announced to invest over €400 million, reinforcing its commitment to providing 100 million […]
Ada Health Secures £63m Investment to Enhance Assessment Tech
June 2 2021
Ada Health has secured $90m (£63m) in funding to enhance its health assessment technology. The […]
Leaps by Bayer Leads USD 90 Million Series B Financing in Digital Health Company Ada Health
May 28 2021
Leaps by Bayer, the impact investment arm of Bayer AG, today announces that it has […]
Bayer Invites Young Leaders to Apply for 5th Biennial Youth Ag Summit
May 18 2021
Applications are now open for the 2021 Youth Ag Summit, a global forum and biennially organized […]
Huma Raises $130 Million Financing to Scale its Digital Health Platform for Better Care and Research
May 12 2021
Huma Therapeutics Limited today announces the completion of its latest funding round with financing of approximately […]
Bayer Foundation Supports Scientists in Sub-saharan Africa
May 6 2021
Bayer Foundation and Alexander von Humboldt Foundation are expanding their existing cooperation. Bayer Foundation provides […]